A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Results 1 to 10 of 139

Thread: (F) Treatment Decisions – Comparisons – Trends

Threaded View

  1. #1

    (F) Treatment Decisions – Comparisons – Trends

    Table of Contents
    A title in all caps does not reflect any emphasis; it is simply how it appeared on the page I copied from.
    Studies in red are new additions.


    [#1] Prostate cancer management choices in patients undergoing multiparametric magnetic resonance imaging/ultrasound fusion biopsy compared to systematic biopsy [2018]

    [#2] Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer [2018]

    [#3] Prostate Cancer Treatment (PDQฎ): Patient Version [2018]

    Prostate Cancer Treatment (PDQฎ): Health Professional Version [Aug. 9, 2018]

    [#4] National trends in management of localized prostate cancer: A population based analysis 2004-2013 [2018]

    [#5] The Association of Long-term Treatment-related Side Effects With Cancer-specific and General Quality of Life Among Prostate Cancer Survivors [2018]

    [#6] Information Seeking and Satisfaction with Information Sources Among Spouses of Men with Newly Diagnosed Local-Stage Prostate Cancer [2018]

    [#7] Understanding Advanced Prostate Cancer Decision Making Utilizing an Interactive Decision Aid [2018]

    [#8] Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis

    [#9] The Diagnosis and Treatment of Prostate Cancer: A Review [2017]

    [#10] Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions [2016]

    [#11] Genomic Markers in Prostate Cancer Decision Making [2018]

    [#12] Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities [2017]

    [#13] Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer [2017]

    [#14] Management and outcomes of Gleason six prostate cancer detected on needle biopsy: A single-surgeon experience over 6 years [2017]

    [#15] Risk of Death from Prostate Cancer with and without Definitive Local Therapy when Gleason Pattern 5 is Present: A Surveillance, Epidemiology, and End Results Analysis [2017]

    [#16] Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer [2017]

    [#17] MISINFORMATION ON THE INTERNET REGARDING ABLATIVE THERAPIES FOR PROSTATE CANCER [2018]

    [#18] Perceptions about cancer clinical trials among prostate cancer survivors [2018]

    [#19] Occurrence of pathologic stage T3 disease at radical prostatectomy with isup grade group 1 (Gleason 3+3=6) prostate cancer [2018]

    [#20] Undertreatment of Elderly Men With High-Risk Prostate Cancer [2017]

    [#21] Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer [2017]

    [#22] Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data [2018]

    [#23] Brachytherapy-Based Radiotherapy and Radical Prostatectomy Are Associated With Similar Survival in High-Risk Localized Prostate Cancer [2018]

    Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer [2017]

    [#24] Association Between Primary Local Treatment and Non–prostate Cancer Mortality in Men With Nonmetastatic Prostate Cancer [2018]

    [#25] Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer [2017]

    [#26] Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer [2018]

    [#27] Oncological impact of neoadjuvant hormonal therapy on permanent iodine‐125 seed brachytherapy in patients with low‐ and intermediate‐risk prostate cancer [2018]

    [#28] Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients? [2018]

    Erectile Function Recovery After Surgery in Young Men with Low-risk Prostate Cancer: Probably Not Just a Matter of Age, Certainly Not the Main Point of Discussion [2018]

    [#29] Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [2018]

    [#30] The Effect of Radical Prostatectomy, External Beam Radiation Therapy and Active Surveillance on Life Insurance Premiums in Patients with Prostate Cancer [2017]

    [#31] Safety and Efficacy of Prostatic Artery Chemoembolization for Prostate Cancer—Initial Experience [2018]

    [#32] Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis [2018]

    [#33] Clinical Case Discussion: Primary Treatment for Prostate Cancer in an Elderly Man—Treatment of the Primary Tumor is Necessary [2018]

    [#34] A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy [2018]

    [#35] The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation [2018]

    [#36] Is fatal family history in prostate cancer a predictor of radical prostatectomy outcomes? [2018]

    [#37] Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy [2018]

    [#38] Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer [2018]

    [#39] Reducing overtreatment of prostate cancer by radical prostatectomy in Eastern Ontario: a population-based cohort study [2018]

    [#40] The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators [2018]

    [#41] Does Travel Time to a Radiation Facility Impact Patient Decision‐Making Regarding Treatment for Prostate Cancer? A Study of the New Hampshire State Cancer Registry [2018]

    [#42] PROSTATE CANCER PATIENTS’ EXPERIENCE AND PREFERENCES FOR ACQUIRING INFORMATION EARLY IN THEIR CARE [2018]

    [#43] The accuracy of patients’ perceptions of the risks associated with localised prostate cancer treatments [2018]

    [#44] Recent Advances in Prostate Cancer Treatment and Drug Discovery [2018]

    [#45] Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate Cancer [2018]

    [#46] Systemic treatments for high-risk localized prostate cancer [2018]

    [#47] Primary whole‐gland ablation for localized prostate cancer with high‐intensity focused ultrasound: The important predictors of biochemical recurrence [2018]

    [#48] MAKING THEIR DECISIONS FOR PROSTATE CANCER TREATMENT: PATIENTS’ EXPERIENCES AND PREFERENCES RELATED TO PROCESS [2018]

    [#49] ASCO 2018: Ten Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1,503 Patients With Intermediate Risk Prostate Cancer [2018]

    [#50] Suitable sexual health care according to men with prostate cancer and their partners [2018]

    [#51] Understanding Medical Decision-making in Prostate Cancer Care [2018]

    [#52] Primary cryotherapy for localised or locally advanced prostate cancer [2018]

    [#53] Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer? [2018]

    Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer [2017]

    [#54] Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis [2017]

    [#55] Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database [2018]

    [#56] Web-Based Versus Usual Care and Other Formats of Decision Aids to Support Prostate Cancer Screening Decisions: Systematic Review and Meta-Analysis [2018]

    [#57] Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis [2018]

    [#58] Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options [2018]

    Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options [2018]

    AUA, ASTRO, SUO release localized PCa guideline [2018]

    [#59] “Still a Cancer Patient”—Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors [2018]

    TOC Continues Below
    Last edited by DjinTonic; 08-16-2018 at 12:32 PM.

 

Similar Threads

  1. Decisions, decisions. Surgery or remain on AS with Gleason 3+4
    By NightHiker in forum Prostate Cancer Forum
    Replies: 37
    Last Post: 12-22-2014, 02:31 PM
  2. Replies: 36
    Last Post: 10-20-2014, 06:54 PM
  3. Decisions, Decisions......
    By Walnut in forum Prostate Cancer Forum
    Replies: 54
    Last Post: 03-12-2014, 04:49 PM
  4. Replies: 0
    Last Post: 07-23-2005, 04:00 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •